R-Biopharm launches as one of the first companies a real-time RT-PCR test for the detection of current coronavirus species
As an innovative company we addressed the need to react to the threat of a coronavirus pandemic and developed the new RIDA®GENE SARS-CoV-2 RUO test that can be ordered from now on.
Key features of the RIDA®GENE SARS-CoV-2 RUO test:
- Real-time multiplex RT-PCR
- Time to result: less than 2 hours
- Detection of coronavirus SARS-CoV-2
- Qualitative detection of SARS-CoV-2 specific RNA from respiratory samples
- Flexible – the assays can be run on many commonly used real-time PCR instruments, such as the Mx3005P, LightCycler®480II, ABI 7500, CFX96 or Rotor-Gene Q or RIDA®CYCLER
- Reliable – an included extraction control (Internal control RNA, ICR) detects PCR inhibition, monitors reagent integrity and confirms that nucleic acid extraction was sufficient
- For research use only
For more information contact apDia
https://clinical.r-biopharm.com/news/r-biopharm-launches-as-one-of-the-first-companies-a-real-time-rt-pcr-for-the-detection-of-current-coronavirus-species/